These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 2137611)

  • 41. General repression of enhanson activity by the adenovirus-2 E1A proteins.
    Rochette-Egly C; Fromental C; Chambon P
    Genes Dev; 1990 Jan; 4(1):137-50. PubMed ID: 2155159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Kao SY; Calman AF; Luciw PA; Peterlin BM
    Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X.
    Twu JS; Rosen CA; Haseltine WA; Robinson WS
    J Virol; 1989 Jun; 63(6):2857-60. PubMed ID: 2724417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cis and trans activation of adenovirus IVa2 gene transcription.
    Natarajan V; Salzman NP
    Nucleic Acids Res; 1985 Jun; 13(11):4067-83. PubMed ID: 2989786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.
    Gendelman HE; Phelps W; Feigenbaum L; Ostrove JM; Adachi A; Howley PM; Khoury G; Ginsberg HS; Martin MA
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9759-63. PubMed ID: 2432602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells.
    Smith DH; Ziff EB
    Mol Cell Biol; 1988 Sep; 8(9):3882-90. PubMed ID: 2975754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription.
    Borrelli E; Hen R; Chambon P
    Nature; 1984 Dec 13-19; 312(5995):608-12. PubMed ID: 6095113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
    Swingler S; Easton A; Morris A
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.
    Sol N; Morinet F; Alizon M; Hazan U
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():2011-4. PubMed ID: 8376975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation.
    Culp JS; Webster LC; Friedman DJ; Smith CL; Huang WJ; Wu FY; Rosenberg M; Ricciardi RP
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6450-4. PubMed ID: 2970640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The HIV-1 regulatory protein Nef has a specific function in viral expression in a murine macrophage cell line.
    Murphy KM; Sweet MJ; Hume DA
    J Leukoc Biol; 1994 Sep; 56(3):294-303. PubMed ID: 8083602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin gene enhancer activity is inhibited by adenovirus 5 E1a gene products.
    Stein RW; Whelan J
    Mol Cell Biol; 1989 Oct; 9(10):4531-4. PubMed ID: 2531280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conditional regulatory elements of human immunodeficiency virus type 2 long terminal repeat.
    Arya SK; Mohr JR
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2253-60. PubMed ID: 8077923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An adenovirus type 5 E1A protein with a single amino acid substitution blocks wild-type E1A transactivation.
    Glenn GM; Ricciardi RP
    Mol Cell Biol; 1987 Mar; 7(3):1004-11. PubMed ID: 2951587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
    Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
    Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upstream DNA sequences determine different autoregulatory responses of the adenovirus types 5 and 3 E1A promoters.
    Jones SN; Tibbetts C
    J Virol; 1989 Apr; 63(4):1833-8. PubMed ID: 2522560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
    Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells.
    Duerksen-Hughes PJ; Hermiston TW; Wold WS; Gooding LR
    J Virol; 1991 Mar; 65(3):1236-44. PubMed ID: 1825340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adenovirus E1A gene autorepression: revertants of an E1A promoter mutation encode altered E1A proteins.
    Larsen PL; Tibbetts C
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8185-9. PubMed ID: 2960973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ; Karn J
    EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.